JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
TRIP.COM-S
09961
NTES-S
09999
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 1.81%44.09B | -13.40%87.17B | -9.02%43.3B | 19.89%100.66B | 16.86%47.59B | 5.49%83.96B | 5.24%40.73B | -7.12%79.59B | -11.72%38.7B | -6.27%85.69B |
Operating income | 1.81%44.09B | -13.40%87.17B | -9.02%43.3B | 19.89%100.66B | 16.86%47.59B | 5.49%83.96B | 5.24%40.73B | -7.12%79.59B | -11.72%38.7B | -6.27%85.69B |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Selling expenses | 11.25%-15.32B | 24.28%-30.83B | 14.41%-17.26B | -41.59%-40.71B | -43.31%-20.16B | -5.77%-28.75B | -3.59%-14.07B | 17.54%-27.18B | 23.77%-13.58B | 3.64%-32.97B |
Employee expense | -11.69%-2.64B | -1.74%-4.75B | 5.37%-2.36B | 8.60%-4.67B | 2.80%-2.5B | -5.43%-5.11B | -13.53%-2.57B | -6.81%-4.84B | 0.04%-2.26B | -1.93%-4.54B |
Depreciation and amortization | -4.50%-4.55B | 3.48%-8.59B | 7.65%-4.36B | 4.34%-8.9B | -3.17%-4.72B | -9.82%-9.31B | -10.88%-4.57B | -4.41%-8.48B | -2.94%-4.13B | -1.41%-8.12B |
Special items of operating profit | -0.88%-14.22B | 25.82%-33.69B | 50.25%-14.1B | -52.94%-45.41B | -109.25%-28.34B | -21.83%-29.69B | -20.43%-13.54B | 24.83%-24.37B | 41.63%-11.25B | -21.90%-32.42B |
Operating profit | 40.77%7.36B | 858.44%9.32B | 164.32%5.23B | -91.24%972M | -235.99%-8.12B | -24.57%11.1B | -20.19%5.97B | 92.39%14.72B | 1,449.69%7.49B | -57.88%7.65B |
Financing income | -20.93%102M | 11.11%270M | 67.53%129M | 125.00%243M | 60.42%77M | -20.59%108M | -37.66%48M | -16.05%136M | -24.51%77M | -15.63%162M |
Financing cost | -5.81%-1.09B | -2.59%-2.14B | -18.76%-1.03B | -19.55%-2.09B | 3.87%-869M | 6.89%-1.74B | -1.80%-904M | 5.55%-1.87B | 8.74%-888M | 3.22%-1.98B |
Share of profits of associates | -28.25%912M | -4.03%2.05B | 11.98%1.27B | 3.09%2.14B | 20.11%1.14B | 20.06%2.07B | 8.62%945M | -5.63%1.73B | -4.92%870M | 0.55%1.83B |
Share of profit from joint venture company | -21.36%519M | 252.92%1.15B | 1,900.00%660M | 435.05%325M | -82.99%33M | -112.17%-97M | -64.40%194M | -9.94%797M | 28.24%545M | 70.85%885M |
Earning before tax | 24.68%7.8B | 569.37%10.64B | 180.70%6.25B | -86.10%1.59B | -223.83%-7.75B | -26.20%11.44B | -22.65%6.26B | 81.49%15.5B | 749.68%8.09B | -54.18%8.54B |
Tax | -93.76%-1.37B | -2,786.41%-2.97B | -125.23%-705M | 94.76%-103M | 348.58%2.79B | 34.35%-1.97B | 28.68%-1.12B | -7.39%-2.99B | -19.39%-1.58B | 30.57%-2.79B |
After-tax profit from continuing operations | 15.90%6.43B | 415.80%7.67B | 211.99%5.55B | -84.30%1.49B | -196.51%-4.95B | -24.26%9.47B | -21.19%5.13B | 117.38%12.51B | 1,869.84%6.51B | -60.66%5.75B |
Earning after tax | 15.90%6.43B | 415.80%7.67B | 211.99%5.55B | -84.30%1.49B | -196.51%-4.95B | -24.26%9.47B | -21.19%5.13B | 117.38%12.51B | 1,869.84%6.51B | -60.66%5.75B |
Minority profit | -2.15%409M | 106.60%876M | 348.81%418M | -49.82%424M | -137.42%-168M | -7.55%845M | 3.46%449M | 3.28%914M | 4.83%434M | 7.01%885M |
Profit attributable to shareholders | 17.37%6.02B | 539.13%6.79B | 207.19%5.13B | -87.68%1.06B | -202.18%-4.79B | -25.57%8.63B | -22.95%4.68B | 138.12%11.59B | 877.37%6.08B | -64.72%4.87B |
Basic earnings per share | 18.00%2.36 | 610.81%2.63 | 204.17%2 | -88.99%0.37 | -204.92%-1.92 | -25.83%3.36 | -23.11%1.83 | 146.20%4.53 | 761.11%2.38 | -65.67%1.84 |
Diluted earnings per share | 18.00%2.36 | 610.81%2.63 | 204.17%2 | -88.99%0.37 | -204.92%-1.92 | -25.83%3.36 | -23.11%1.83 | 146.20%4.53 | 761.11%2.38 | -65.67%1.84 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.